Projected Income Statement: Ameren Corporation

Forecast Balance Sheet: Ameren Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 13,604 15,085 16,481 18,715 19,817 22,140 24,821 27,330
Change - 10.89% 9.25% 13.56% 5.89% 11.72% 12.11% 10.11%
Announcement Date 17/02/22 15/02/23 22/02/24 13/02/25 11/02/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Ameren Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 2,954 3,351 3,597 4,319 4,128 5,558 6,560 6,781
Change - 13.44% 7.34% 20.07% -4.42% 34.64% 18.03% 3.36%
Free Cash Flow (FCF) 1 -1,293 -1,088 -1,033 -1,556 -775 -5,782 -7,375 -3,737
Change - 15.85% 5.06% -50.63% 50.19% -646.06% -27.55% 49.33%
Announcement Date 17/02/22 15/02/23 22/02/24 13/02/25 11/02/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Ameren Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 38.77% 35.24% 39.27% 40.75% 40.85% 44.05% 45.75% 47.69%
EBIT Margin (%) 20.85% 19.04% 20.77% 19.89% 23.03% 25.28% 26.9% 28.7%
EBT Margin (%) 18.02% 15.77% 17.87% 16.66% 18.15% 19.14% 20.05% 21.04%
Net margin (%) 15.48% 13.5% 15.36% 15.51% 16.55% 16.33% 17% 17.85%
FCF margin (%) -20.22% -13.67% -13.77% -20.41% -8.81% -63.26% -75.97% -36.17%
FCF / Net Income (%) -130.61% -101.3% -89.67% -131.64% -53.23% -387.38% -446.94% -202.61%

Profitability

        
ROA 2.92% 2.92% 2.93% 2.77% 3.13% 2.89% 2.95% 3.07%
ROE 10.62% 10.5% 10.54% 10.08% 11.41% 10.67% 10.69% 10.78%

Financial Health

        
Leverage (Debt/EBITDA) 5.49x 5.38x 5.6x 6.03x 5.51x 5.5x 5.59x 5.55x
Debt / Free cash flow -10.52x -13.86x -15.95x -12.03x -25.57x -3.83x -3.37x -7.31x

Capital Intensity

        
CAPEX / Current Assets (%) 46.2% 42.11% 47.96% 56.66% 46.91% 60.81% 67.58% 65.63%
CAPEX / EBITDA (%) 119.16% 119.51% 122.14% 139.05% 114.86% 138.05% 147.7% 137.62%
CAPEX / FCF (%) -228.46% -308% -348.21% -277.57% -532.65% -96.13% -88.95% -181.45%

Items per share

        
Cash flow per share 1 6.448 8.721 9.734 10.33 12.32 12.89 13.61 -
Change - 35.25% 11.62% 6.15% 19.21% 4.66% 5.55% -
Dividend per Share 1 2.2 2.36 2.52 2.68 2.84 3.009 3.221 3.415
Change - 7.27% 6.78% 6.35% 5.97% 5.95% 7.05% 6.03%
Book Value Per Share 1 37.64 40.11 42.62 44.88 48.48 52.39 56.44 60.82
Change - 6.56% 6.26% 5.3% 8.02% 8.07% 7.72% 7.77%
EPS 1 3.84 4.14 4.38 4.42 5.35 5.398 5.834 6.349
Change - 7.81% 5.8% 0.91% 21.04% 0.89% 8.09% 8.83%
Nbr of stocks (in thousands) 257,606 258,522 262,945 266,928 270,495 276,843 276,843 276,843
Announcement Date 17/02/22 15/02/23 22/02/24 13/02/25 11/02/26 - - -
1USD
Estimates
2026 *2027 *
P/E 18.9x 17.5x
PBR 1.95x 1.81x
EV / Sales 5.52x 5.47x
Yield 2.94% 3.15%

EPS & Dividend



Y-o-Y evolution of P/E

 

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
102.23USD
Average target price
120.00USD
Spread / Average Target
+17.38%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AEE Stock
  4. Financials Ameren Corporation
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!